Home/Filings/4/0001415889-25-009369
4//SEC Filing

Jin David 4

Accession 0001415889-25-009369

CIK 0001429260other

Filed

Mar 31, 8:00 PM ET

Accepted

Apr 1, 4:20 PM ET

Size

5.2 KB

Accession

0001415889-25-009369

Insider Transaction Report

Form 4
Period: 2025-04-01
Jin David
Chief Financial Officer
Transactions
  • Award

    Common Stock, par value $0.001

    2025-04-01$1.22/sh+5,000$6,0781,245,893 total
Footnotes (2)
  • [F1]The reporting person is voluntarily reporting an acquisition of shares under the Issuer's Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c).
  • [F2]Total holdings include 1,230,000 shares underlying deferred restricted stock units.

Issuer

Fortress Biotech, Inc.

CIK 0001429260

Entity typeother

Related Parties

1
  • filerCIK 0001930732

Filing Metadata

Form type
4
Filed
Mar 31, 8:00 PM ET
Accepted
Apr 1, 4:20 PM ET
Size
5.2 KB